Literature DB >> 8690174

A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.

G Paolisso1, P A Tataranni, J E Foley, C Bogardus, B V Howard, E Ravussin.   

Abstract

To assess the role of fasting plasma non-esterified fatty acids (NEFA) in the development of non-insulin-dependent diabetes mellitus (NIDDM), data were analysed from annual examinations of 190 non-diabetic Pima Indians. Glucose tolerance was measured by a 75-g oral glucose tolerance test, insulin action by a euglycaemic hyperinsulinaemic (40 mU x m-2 x min-1) clamp and in vitro lipolysis using isolated abdominal fat cells. After a mean follow-up period of 4.0 +/- 2.4 years (mean +/- SD), 47 subjects developed NIDDM. Risk factors for NIDDM were estimated by proportional-hazards analysis and risk ratios (RR) with 95% confidence intervals (95% CI) calculated at the 90th and 10th percentile of the predictor variables. A large average fat-cell volume was predictive of NIDDM (RR=2.4; 95% CI=1.2-4.8) independent of age, sex, percent body and body fat distribution. A high fasting plasma NEFA concentration was also a risk factor for NIDDM (RR=2.3; 95% CI=1.1-4.7) independent of sex, percent body fat, waist/thigh ratio, insulin-mediated glucose uptake and fasting triglyceride concentration. We conclude that large fat cells and the resulting increased plasma NEFA concentrations are risk factors for the development of NIDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8690174     DOI: 10.1007/bf00422371

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

3.  Assay of insulin-like activity by the isolated fat cell method. I. Factors influencing the response to crystalline insulin.

Authors:  J Gliemann
Journal:  Diabetologia       Date:  1967-08       Impact factor: 10.122

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 5.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

6.  Insulin sensitivity in adipocytes from subjects with varying degrees of glucose tolerance.

Authors:  J E Foley; P Thuillez; S Lillioja; J Zawadzki; C Bogardus
Journal:  Am J Physiol       Date:  1986-09

7.  Effect of fatty acids on glucose production and utilization in man.

Authors:  E Ferrannini; E J Barrett; S Bevilacqua; R A DeFronzo
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

8.  Correlations of glycogen synthase and phosphorylase activities with glycogen concentration in human muscle biopsies. Evidence for a double-feedback mechanism regulating glycogen synthesis and breakdown.

Authors:  R Munger; E Temler; D Jallut; E Haesler; J P Felber
Journal:  Metabolism       Date:  1993-01       Impact factor: 8.694

9.  In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.

Authors:  A Kashiwagi; M A Verso; J Andrews; B Vasquez; G Reaven; J E Foley
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

10.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.

Authors:  Y P Zhou; V E Grill
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more
  94 in total

1.  Genome-wide identification of palmitate-regulated immediate early genes and target genes in pancreatic beta-cells reveals a central role of NF-κB.

Authors:  Hyung Jin Choi; Seungwoo Hwang; Se-Hee Lee; You Ri Lee; Jiyon Shin; Kyong Soo Park; Young Min Cho
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

2.  Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients.

Authors:  Bjorn Eliasson; Ulf Smith; Shawn Mullen; Samuel W Cushman; Arthur S Sherman; Jian Yang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

3.  Nonesterified fatty acids and risk of sudden cardiac death in older adults.

Authors:  Luc Djoussé; Mary L Biggs; Joachim H Ix; Jorge R Kizer; Rozenn N Lemaitre; Nona Sotoodehnia; Susan J Zieman; Dariush Mozaffarian; Russell P Tracy; Kenneth J Mukamal; David S Siscovick
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-26

4.  Protein tyrosine phosphatase-1B (PTP-1B) knockdown improves palmitate-induced insulin resistance in C2C12 skeletal muscle cells.

Authors:  Salar Bakhtiyari; Reza Meshkani; Mohammad Taghikhani; Bagher Larijani; Khosrow Adeli
Journal:  Lipids       Date:  2010-02-23       Impact factor: 1.880

Review 5.  Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state.

Authors:  Luc J C van Loon; Bret H Goodpaster
Journal:  Pflugers Arch       Date:  2005-09-10       Impact factor: 3.657

Review 6.  Emerging paradigms for understanding fatness and diabetes risk.

Authors:  Steven R Smith; Eric Ravussin
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 7.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

8.  Insulin sensitivity is related to fat oxidation and protein kinase C activity in children with acute burn injury.

Authors:  Melanie G Cree; Jennifer J Zwetsloot; David N Herndon; Bradley R Newcomer; Ricki Y Fram; Carlos Angel; Justin M Green; Gerald L Dohm; Dayoung Sun; Asle Aarsland; Robert R Wolfe
Journal:  J Burn Care Res       Date:  2008 Jul-Aug       Impact factor: 1.845

9.  Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.

Authors:  Patrick Yue; Hong Jin; Shiming Xu; Marissa Aillaud; Alicia C Deng; Junya Azuma; Ramendra K Kundu; Gerald M Reaven; Thomas Quertermous; Philip S Tsao
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

Review 10.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.